MSL-109 adjuvant therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: The monoclonal antibody cytomegalovirus retinitis trial

Douglas A. Jabs

Research output: Contribution to journal › Article › peer-review

37 Scopus citations

Fingerprint

Dive into the research topics of 'MSL-109 adjuvant therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: The monoclonal antibody cytomegalovirus retinitis trial'. Together they form a unique fingerprint.

Medicine & Life Sciences